LGR5 and cancer: This is especially important when considering clinical treatment as this phenomenon has also been observed in tumours where differentiated tumour cells (non-Lgr5 + ) can be reactivated following cancer stem cell depletion and subsequently dedifferentiate and fuel tumour growth9,10.